Increased serum complement C3 and C4 concentrations and their relation to severity of chronic spontaneous urticaria and CRP concentration

Journal of Inflammation (United Kingdom)

Volumn 10, Issue 1, 2013, Pages

  Kasperska Zajac, Alicja ^a   Grzanka, Alicja ^b   Machura, Edyta ^b   Misiolek, Maciej ^b   Mazur, Bogdan ^b   Jochem, Jerzy ^b  

^a Allergology and Clinical Immunology   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Acute phase response; C3; C4; Chronic urticaria; Complement

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ARTICLE; CHRONIC URTICARIA; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; PROTEIN DETERMINATION;

EID: 84879083687     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-10-22     Document Type: Article

References (18)

1. Acute-phase response in chronic urticaria. Kasperska-Zajac A, J Eur Acad Dermatol Venereol 2012 26 665 672 10.1111/j.1468-3083.2011.04366.x 22118494
2. Analysis of procalcitonin and CRP concentrations in serum of patients with chronic spontaneous urticaria. Kasperska-Zajac A, Grzanka A, Machura E, Mazur B, Misiolek M, Czecior E, Kasperski J, Jochem J, Inflamm Res 2013 62 309 312 10.1007/s00011-012-0580-1 23207551
3. Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria. Kasperska-Zajac A, Brzoza Z, Rogala B, Cytokine 2007 39 142 146 10.1016/j.cyto.2007.06.008 17827029
4. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Kasperska-Zajac A, Sztylc J, Machura E, Jop G, Clin Exp Allergy 2011 41 1386 1391 10.1111/j.1365-2222.2011.03789.x 21645137
5. Activation of blood coagulation in plasma from chronic urticaria patients with negative autologous plasma skin test. Asero R, Cugno M, Tedeschi A, J Eur Acad Dermatol Venereol 2011 25 201 205 10.1111/j.1468-3083.2010.03752.x 20561123
6. Increased mean platelet volume and C-reactive protein levels in patients with chronic urticaria with a positive autologous serum skin test. Magen E, Mishal J, Zeldin Y, Feldman V, Kidon M, Schlesinger M, Sthoeger Z, Am J Med Sci 2010 339 504 508 20400886
7. Sex hormones and urticaria. Kasperska-Zajac A, Brzoza Z, Rogala B, J Dermatol Sci 2008 52 79 86 10.1016/j.jdermsci.2008.04.002 18485675
8. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. Kikuchi Y, Kaplan AP, J Allergy Clin Immunol 2002 109 114 118 10.1067/mai.2002.120954 11799375
9. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY, J Clin Lab Anal 2004 18 1 8 10.1002/jcla.10100 14730550
10. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Takahagi S, Mihara S, Iwamoto K, Morioke S, Okabe T, Kameyoshi Y, Hide M, Allergy 2010 65 649 656 10.1111/j.1398-9995.2009.02222.x 19845571
11. The role of the anaphylatoxins in health and disease. Klos A, Tenner AJ, Johswich KO, Ager RR, Reis ES, Köhl J, Mol Immunol 2009 46 2753 2766 10.1016/j.molimm.2009.04.027 19477527
12. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. el-Lati SG, Dahinden CA, Church MK, J Invest Dermatol 1994 102 803 806 10.1111/1523-1747.ep12378589 7513741
13. Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5. Fukuoka Y, Xia HZ, Sanchez-Muñoz LB, Dellinger AL, Escribano L, Schwartz LB, J Immunol 2008 180 6307 6316 18424754
14. Co-existence of Chronic Urticaria and Metabolic Syndrome: Clinical Implications. Ye YM, Jin HJ, Hwang EK, Nam YH, Kim JH, Shin YS, Park HS, Acta Derm Venereol 2013 93 156 160 10.2340/00015555-1443 22948845
15. Complement component profiles in urticaria, dermatitis herpetiformis, and alopecia areata. Berrens L, Jankowski E, Jankowski-Berntsen I, Br J Dermatol 1976 95 145 152 10.1111/j.1365-2133.1976.tb00817.x 952750
16. Efficacy of montelukast as added therapy in patients with chronic idiopathic urticaria. Khan S, Lynch N, Inflamm Allergy Drug Targets 2012 11 235 243 10.2174/187152812800392742 22452602
17. Reactivity to autologous serum skin test and relationship with complement levels in chronic idiopathic urticaria and angio-oedema. Zamiri M, Jury CS, Dawe RS, O'Neill S, Douglas WS, Clin Exp Dermatol 2009 34 587 590 10.1111/j.1365-2230.2008.03032.x 19094131
18. Complement C3 and cleavage products in cardiometabolic risk. Onat A, Can G, Rezvani R, Cianflone K, Clin Chim Acta 2011 412 1171 1179 10.1016/j.cca.2011.03.005 21419112